Position in SNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,659,076
+$642,045 QoQ
Shares Held
85,773
+37.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#140
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. SNY ranks #6 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
This page
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,659,076 | 85,773 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,017,031 | 62,620 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,951,553 | 60,907 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,775,643 | 58,806 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,765,844 | 57,252 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,088,068 | 55,681 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,652,698 | 55,001 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,158,124 | 54,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,639,439 | 54,399 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,603,599 | 53,572 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,608,239 | 52,448 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,923,165 | 54,496 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,907,581 | 53,944 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,865,593 | 52,657 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,444,438 | 71,122 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,724,931 | 71,671 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,440,513 | 48,781 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,407,691 | 46,897 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,169,029 | 43,294 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,000,473 | 41,495 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,983,438 | 37,665 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,750,636 | 35,395 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,596,473 | 32,856 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,380,427 | 27,515 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,359,104 | 26,623 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,576,630 | 36,062 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||